Anterogen Co (XKRX:065660) Short-Term Debt : ₩0 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Short-Term Debt?

Anterogen Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩0 Mil.

Anterogen Co's quarterly Short-Term Debt increased from Sep. 2023 (₩9,398 Mil) to Dec. 2023 (₩9,740 Mil) but then declined from Dec. 2023 (₩9,740 Mil) to Mar. 2024 (₩0 Mil).

Anterogen Co's annual Short-Term Debt increased from Dec. 2021 (₩11,770 Mil) to Dec. 2022 (₩12,711 Mil) but then declined from Dec. 2022 (₩12,711 Mil) to Dec. 2023 (₩9,740 Mil).

Anterogen Co Short-Term Debt Historical Data

The historical data trend for Anterogen Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Short-Term Debt Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

8,347.48

9,252.89

11,770.36

12,711.15

9,740.40

Anterogen Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															13,151.77	9,070.97	9,398.33	9,740.40	-

Anterogen Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Anterogen Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co (XKRX:065660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines